The long-term goal of this research is to study how CREB binding protein (CBP), a transcriptional coactivator, helps orchestrate mRNA nuclear export. Two proteins, an RNA shuttling protein called TLS (translocated in liposarcoma) and PRMT2 (protein arginine methyltransferase 2), were identified as novel CBP-interacting proteins. This project tests the hypothesis that a PRMT protein methylates TLS and TLS arginine methylation determines its subcellular localization. In vitro methylation assays will test which PRMT family member preferentially methylates TLS. To show whether TLS arginine methylation determines its subcellular localization, cells expressing a green fluorescent protein (GFP) tagged TLS will be treated with arginine methylase inhibitors and fluorescent microscopy will determine how this affects TLS localization. A mutant GFP-TLS protein will also be made, changing the arginines residues to lysines, and fluorescent microscopy used to determine its subcellular localization. Finally, biochemical techniques will be used to identify proteins that preferentially interact with methylated TLS. This work has the potential to link CBP.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM066563-03
Application #
6747337
Study Section
Special Emphasis Panel (ZRG1-F05 (20))
Program Officer
Tompkins, Laurie
Project Start
2002-07-01
Project End
2004-12-31
Budget Start
2004-07-01
Budget End
2004-12-31
Support Year
3
Fiscal Year
2004
Total Cost
$24,464
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Fass, Daniel M; Butler, Jennifer E F; Goodman, Richard H (2003) Deacetylase activity is required for cAMP activation of a subset of CREB target genes. J Biol Chem 278:43014-9